Nasacort AQ is often prescribed for the treatment of runny nose, nasal stuffiness, itchiness, and sneezing associated with seasonal and perennial allergies. It is approved for use in both adults and children as young as two years old. Nasacort AQ comes in nasal spray form and is generally used once a day.
What Is Nasacort AQ?
Nasacort® AQ (triamcinolone nasal spray) is a prescription nasal spray licensed to treat sneezing, runny or stuffy nose, and nasal itching due to allergies (known medically as allergic rhinitis) in adults and children as young as two years old. This medication can be used to treat both allergies that occur all year long (known as perennial allergies) and seasonal allergies.
Nasacort AQ is available by prescription only. However, Nasacort Allergy 24HR is available without a prescription. These two products are the same strength.
Allergies occur when a person's immune system reacts to normally harmless substances that do not bother most people. This immune system reaction is known as inflammation and involves several different types of cells and several different chemicals in the body.
Nasacort AQ is a corticosteroid, or simply "steroid" for short. Steroids can have many different effects in the body, including anti-inflammatory effects. Steroids decrease inflammation by limiting the body's ability to produce an immune system reaction. They can be effective for treating conditions such as allergies. However, long-term use can cause bothersome and sometimes serious side effects, and this limits their usefulness. Because Nasacort AQ is a nasal spray, its effects are generally limited to the nose. This helps prevent many of the long-term side effects of steroids.
Nasacort AQ [package insert]. Bridgewater, NJ: sanofi-aventis U.S., LLC;September 2008.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 5, 2011.
Perrigo Company. Perrigo announces FDA approval for generic version of Nasacort® AQ (8/3/09). Perrigo Web site. Available at: http://www.perrigo.com/uploadedFiles/Investors/Press_Releases/PRGOPR(16).pdf. Accessed September 17, 2009.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed August 2, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click